This issue of Cardiology Clinics examines pacemakers and implantable cardioverter defibrillators (ICD). Topics include device selection, indications and guidelines for device therapy, shock avoidance, lead advisories and recalls, lead extraction, subcutaneous ICDs, device tools to manage the heart failure patient, and many more.
Consisting of 13 chapters, this book is uniformly written to provide sensible, matter-of-fact methods for understanding and caring for patients with permanent pacemakers, ICDs and CRT systems. Now improved and updated, including a new chapter on programming and optimization of CRT devices, this second edition presents a large amount of information in an easily digestible form. Cardiac Pacing and Defibrillation offers sensible, matter-of-fact methods for understanding and caring for patients, making everyday clinical encounters easier and more productive. Readers will appreciate the knowledge and experience shared by the authors of this book.
In the rapidly evolving field of treating cardiac arrhythmias, the importance of direct management of patients with implantable cardiac devices is growing. The devices have become increasingly complex, and understanding their algorithms and growing programming options is essential for physicians who implant and manage them. Written by experts and world authorities in the field, Pacemakers and Implantable Cardioverter Defibrillators: An Expert's Manual provides electrophysiologists, fellows in training, nurses, and cardiovascular technicians involved in day-to-day management of device patients with detailed information about the many device algorithms and interactions. Heavily illustrated with over 300 figures and tables Uniquely meets the day-to-day needs of all direct management professionals Focuses in detail on algorithms Describes device interactions, addressing every major manufacturer Provides in-depth insight into pacing, including biventricular pacing Discusses arrhythmia detection and device classification, testing, and therapy Pacemakers and Implantable Cardioverter Defibrillators: An Expert's Manual was listed by the American Journal of Cardiology as one of the "Good Books in Cardiovascular Disease in 2010." - American Journal of Cardiology Vol. 107, Issue 8, Pages 1250-1251
This concise text presents best practices for all aspects of atrial fibrillation ablation as outlined in the new version of the VeniceChart International Consensus document, which is presented in conjunction with the biannual Venice Arrhythmias conference. In addition to discussing the latest in a-fib ablation research, this 2011 update covers all the key areas of therapy and patient management, including: • Techniques and technologies • Procedural endpoints • Patient management pre-, peri- and post-ablation • Prevention and treatment of complications • Definition of success and long-term results With contributions from the world’s recognized thought leaders in this field, this book is a highly valuable source of information not only for specialists in electrophysiology, but also for general cardiologists, fellows in cardiology and others interested in this dynamic and increasingly important topic.
Over 5.7 million people in America carry a diagnosis of heart failure, the incidence of which approaches 1 in 100 people over the age of 65. The cost to society is estimated at $29 billion annually and over 1.1 million hospital admissions. For hospitalized heart failure patients, the 30-day readmission rate approaches 25%. As our population ages these numbers are expected to grow. This issue of Cardiology Clinics helps practitioners to manage patients at all ACC/AHA stages of heart failure and addresses key issues that include sudden cardiac death, arrhythmias, acute decompensated heart failure, and heart failure with preserved ejection fraction.
This collection explores the subject of conflicts of interest. It investigates how to manage conflicts of interest, how they can affect well-meaning professionals, and how they can limit the effectiveness of corporate boards, undermine professional ethics, and corrupt expert opinion. Legal and policy responses are considered, some of which (e.g. disclosure) are shown to backfire and even fail. The results offer a sobering prognosis for professional ethics and for anyone who relies on professionals who have conflicts of interest. The contributors are leading authorities on the subject in the fields of law, medicine, management, public policy, and psychology. The nuances of the problems posed by conflicts of interest will be highlighted for readers in an effort to demonstrate the many ways that structuring incentives can affect decision making and organizations' financial well-being.
The entire spectrum of vascular disease is examined in this issue of Cardiology Clinics. Topics include carotid artery disease, endovascular interventions for thoracic and abdominal aortic aneurismal disease, critical limb ischemia, contemporary treatment of venous thromboembolic disease, renal artery stenosis, resistant hypertension, advances in peripheral arterial disease revascularization, stroke interventions, medical management of PAD, pre-operatory evaluation of vascular patients.
Atrial fibrillation is the most common cardiac arrhythmia. This issue of Cardiology Clinics examines following facets of atrial fibrillation: epidemiology and societal impact, risk factors and genetics, mechanisms, diagnosis and follow-up, rate versus rhythm control, antiarrhythmic drug therapy, catheter ablation, surgery, antithrombotic and anticoagulant therapy, left atrial appendage exclusion, management of patients with heart failure and structural heart disease, and novel treatment paradigms.
Today hundreds of thousands of Americans carry pacemakers and implantable cardioverter-defibrillators (ICDs) within their bodies. These battery-powered machines—small computers, in fact—deliver electricity to the heart to correct dangerous disorders of the heartbeat. But few doctors, patients, or scholars know the history of these devices or how "heart-rhythm management" evolved into a multi-billion-dollar manufacturing and service industry. Machines in Our Hearts tells the story of these two implantable medical devices. Kirk Jeffrey, a historian of science and technology, traces the development of knowledge about the human heartbeat and follows surgeons, cardiologists, and engineers as they invent and test a variety of electronic devices. Numerous small manufacturing firms jumped into pacemaker production but eventually fell by the wayside, leaving only three American companies in the business today. Jeffrey profiles pioneering heart surgeons, inventors from the realms of engineering and medical research, and business leaders who built heart-rhythm management into an industry with thousands of employees and annual revenues in the hundreds of millions. As Jeffrey shows, the pacemaker (first implanted in 1958) and the ICD (1980) embody a paradox of high-tech health care: these technologies are effective and reliable but add billions to the nation's medical bill because of the huge growth in the number of patients who depend on implanted devices to manage their heartbeats.
To ensure the best outcomes, cardiologist must have a deep understanding of the design, manufacturing, and malfunctions of implantable devices. This issue of Cardiac Electrophysiology thoroughly examines implantable devices, providing the most reliable and updated information. Topics include MRI conditionally safe pacemakers, complications in lead extraction, troubleshooting malfunctioning pacemakers and ICDs.
